Opportunistische Infektionen bei Immunsuppression

Prof. Dr. med. Jens Gottlieb

Forschungsunterstützung: Zambon, Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Lungenforschung, Vortragstätigkeit: AstraZeneca, Novartis, Takeda, CSL Behring, Beratungstätigkeit: Zambon, Pierre Fabre, AstraZeneca, Theravance, Moderna

Prof. Dr. med. Christian Kneitz

Vortragstätigkeit: AbbVie, Berlin-Chemie, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Chugai, Galapagos, Gilead, GSK, Janssen, Lilly, Medac, MSD, Novartis, Oxford Immunotec, Pfizer, Roche, Sanofi, Takeda, UCB, Beratungstätigkeit: UCB, Boehringer

Prof. Dr. med. Oliver Cornely

Grants or contracts: Amplyx, Basilea, BMBF, Cidara, DZIF, EU-DG RTD (101037867), F2G, Gilead, Matinas, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis, Consulting fees: AbbVie, Amplyx, Biocon, Biosys, Cidara, Da Volterra, Gilead, IQVIA, Janssen, Matinas, MedPace, Menarini, Molecular Partners, MSG-ERC, Noxxon, Octapharma, Pfizer, PSI, Scynexis, Seres, Honoraria for lectures: Abbott, AbbVie, Al-Jazeera Pharmaceuticals, Astellas, Gilead, Grupo Biotoscana/United Medical/Knight, Hikma, MedScape, med update, Merck/MSD, Mylan, Noscendo, Pfizer, Shionofi, Payment for expert testimony: Cidara,, Participation on a Data Safety Monitoring Board or Advisory Board: Actelion, Allecra, Cidara, Entasis, IQVIA, Janssen, MedPace, Paratek, PSI, Pulmocide, Shionogi, The Prime Meridian Group, More: A patent at the German Patent and Trade Mark Office ( DE 10 2021 113 007.7); Stocks from CoRe Consulting, EasyRadiology; other interests from DGHO, DGI, ECMM, DZIF, EHA, ISHAM, MSG-ERC, Wiley